Cizzle Financial Statements From 2010 to 2024

Stocks . UK . 
Stock . Cizzle Biotechnology Holdings
CIZ Stock   1.75  0.05  2.78%   
Cizzle Biotechnology financial statements provide useful quarterly and yearly information to potential Cizzle Biotechnology Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cizzle Biotechnology financial statements helps investors assess Cizzle Biotechnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cizzle Biotechnology's valuation are summarized below:
Gross Profit
25 K
Market Capitalization
7.1 M
Revenue
25 K
Earnings Share
(0.01)
Revenue Per Share
0.08
There are over seventy-two available fundamental signals for Cizzle Biotechnology Holdings, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Cizzle Biotechnology's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.

Cizzle Biotechnology Total Revenue

0.0

Check Cizzle Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cizzle Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 927, Interest Expense of 7.5 M or Total Revenue of 0.0, as well as many indicators such as . Cizzle financial statements analysis is a perfect complement when working with Cizzle Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Cizzle Biotechnology Technical models . Check out the analysis of Cizzle Biotechnology Correlation against competitors.

Cizzle Biotechnology Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.7 M1.7 M3.4 M
Slightly volatile
Short and Long Term Debt Total10.9311.5370 K
Slightly volatile
Total Current Liabilities176.7 K186 K1.3 M
Slightly volatile
Accounts Payable87.4 K92 K495.3 K
Slightly volatile
Cash136.8 K144 K457.4 K
Slightly volatile
Cash And Short Term Investments1.6 M1.6 M651.4 K
Pretty Stable
Common Stock Shares Outstanding338.1 M355.9 M7.5 B
Slightly volatile
Liabilities And Stockholders Equity2.7 M1.7 M3.4 M
Slightly volatile
Other Current Assets270.9 K136 K305 K
Pretty Stable
Total Liabilities176.7 K186 K1.4 M
Slightly volatile
Total Current Assets1.5 M1.7 M1.9 M
Slightly volatile
Short Term Debt10.9311.5319.4 K
Slightly volatile
Intangible Assets1.3 M2.4 M1.1 M
Very volatile
Common Stock2.7 M3.5 M3.4 M
Slightly volatile
Net Receivables129.2 K136 K782.6 K
Slightly volatile
Other Liabilities1.6 K8361.9 K
Slightly volatile
Accumulated Other Comprehensive Income9.3 M10.6 M6.3 M
Slightly volatile
Property Plant Equipment1.2 K1.3 K4.4 K
Slightly volatile
Capital Surpluse9.7 M10.2 M9 M
Slightly volatile
Capital Stock35.1 K37 K250 K
Pretty Stable
Short Term Investments1.1 M1.3 M1.4 M
Slightly volatile

Cizzle Biotechnology Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses1.1 K1.2 K4.1 M
Slightly volatile
Research Development203214186.4 K
Slightly volatile
Total Operating Expenses1.1 K1.2 K2 M
Slightly volatile
Selling General Administrative9279762 M
Slightly volatile
Interest Income1.711.823.3 K
Slightly volatile
Selling And Marketing Expenses608.8 K684.9 K745.8 K
Slightly volatile

Cizzle Biotechnology Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow516.1 K478 K655.7 K
Slightly volatile
Total Cash From Financing Activities289.8 K305 K802.8 K
Pretty Stable
End Period Cash Flow136.8 K144 K453.2 K
Slightly volatile
Dividends Paid27.2 K30.6 K33.3 K
Slightly volatile
Change To Netincome82.9 K87.3 K2.5 M
Slightly volatile

Cizzle Fundamental Market Drivers

Cash And Short Term Investments1.6 M

About Cizzle Biotechnology Financial Statements

Cizzle Biotechnology stakeholders use historical fundamental indicators, such as Cizzle Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cizzle Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cizzle Biotechnology's assets and liabilities are reflected in the revenues and expenses on Cizzle Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cizzle Biotechnology Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue(11.50)(12.07)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Cizzle Stock

Cizzle Biotechnology financial ratios help investors to determine whether Cizzle Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cizzle with respect to the benefits of owning Cizzle Biotechnology security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY